Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: patient outcomes, rate of appropriate and inappropriate interventions, and complications.

Vriesendorp PA, Schinkel AF, Van Cleemput J, Willems R, Jordaens LJ, Theuns DA, van Slegtenhorst MA, de Ravel TJ, ten Cate FJ, Michels M.

Am Heart J. 2013 Sep;166(3):496-502. doi: 10.1016/j.ahj.2013.06.009. Epub 2013 Jul 16.

PMID:
24016499
2.

Do we need more or better electrophysiology centres?

De Roy LJ, Goethals P, Jordaens LJ.

Europace. 2013 Dec;15(12):1687-9. doi: 10.1093/europace/eut242. Epub 2013 Aug 19. No abstract available.

PMID:
23960090
3.

Early mortality in prophylactic implantable cardioverter-defibrillator recipients: development and validation of a clinical risk score.

Kraaier K, Scholten MF, Tijssen JG, Theuns DA, Jordaens LJ, Wilde AA, van Dessel PF.

Europace. 2014 Jan;16(1):40-6. doi: 10.1093/europace/eut223. Epub 2013 Aug 4.

PMID:
23918791
4.

The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort.

Olde Nordkamp LR, Dabiri Abkenari L, Boersma LV, Maass AH, de Groot JR, van Oostrom AJ, Theuns DA, Jordaens LJ, Wilde AA, Knops RE.

J Am Coll Cardiol. 2012 Nov 6;60(19):1933-9. doi: 10.1016/j.jacc.2012.06.053. Epub 2012 Oct 10.

5.

Adenosine testing after cryoballoon pulmonary vein isolation improves long-term clinical outcome.

Van Belle YL, Janse PA, de Groot NM, Anné W, Theuns DA, Jordaens LJ.

Neth Heart J. 2012 Nov;20(11):447-55. doi: 10.1007/s12471-012-0319-1.

6.

Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis.

Schinkel AF, Vriesendorp PA, Sijbrands EJ, Jordaens LJ, ten Cate FJ, Michels M.

Circ Heart Fail. 2012 Sep 1;5(5):552-9. Epub 2012 Jul 20. Review.

PMID:
22821634
7.

Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy.

Olde Nordkamp LR, Knops RE, Bardy GH, Blaauw Y, Boersma LV, Bos JS, Delnoy PP, van Dessel PF, Driessen AH, de Groot JR, Herrman JP, Jordaens LJ, Kooiman KM, Maass AH, Meine M, Mizusawa Y, Molhoek SG, van Opstal J, Tijssen JG, Wilde AA.

Am Heart J. 2012 May;163(5):753-760.e2. doi: 10.1016/j.ahj.2012.02.012.

8.

A complex double deletion in LMNA underlies progressive cardiac conduction disease, atrial arrhythmias, and sudden death.

Marsman RF, Bardai A, Postma AV, Res JC, Koopmann TT, Beekman L, van der Wal AC, Pinto YM, Lekanne Deprez RH, Wilde AA, Jordaens LJ, Bezzina CR.

Circ Cardiovasc Genet. 2011 Jun;4(3):280-7. doi: 10.1161/CIRCGENETICS.110.959221. Epub 2011 Mar 15.

PMID:
21406687
9.

Minor elevations in troponin I are associated with mortality and adverse cardiac events in patients with atrial fibrillation.

van den Bos EJ, Constantinescu AA, van Domburg RT, Akin S, Jordaens LJ, Kofflard MJ.

Eur Heart J. 2011 Mar;32(5):611-7. doi: 10.1093/eurheartj/ehq491. Epub 2011 Jan 20.

PMID:
21252170
10.

Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.

Soliman OI, Theuns DA, van Dalen BM, Vletter WB, Nemes A, Jordaens LJ, Balk AH, Ten Cate FJ, Geleijnse ML.

Am J Cardiol. 2010 Jan 1;105(1):105-11. doi: 10.1016/j.amjcard.2009.08.659. Epub 2009 Nov 18.

PMID:
20102900
11.

Usefulness of remote magnetic navigation for ablation of ventricular arrhythmias originating from outflow regions.

Schwagten BK, Szili-Torok T, Rivero-Ayerza M, Jessurun E, Valk S, Jordaens LJ.

Neth Heart J. 2009 Jun;17(6):245-9.

12.

Usefulness of left ventricular systolic dyssynchrony by real-time three-dimensional echocardiography to predict long-term response to cardiac resynchronization therapy.

Soliman OI, Geleijnse ML, Theuns DA, van Dalen BM, Vletter WB, Jordaens LJ, Metawei AK, Al-Amin AM, ten Cate FJ.

Am J Cardiol. 2009 Jun 1;103(11):1586-91. doi: 10.1016/j.amjcard.2009.01.372. Epub 2009 Apr 8.

PMID:
19463520
13.

Quantification of left ventricular systolic dyssynchrony by real-time three-dimensional echocardiography.

Soliman OI, van Dalen BM, Nemes A, Zwaan HB, Vletter WB, ten Cate FJ, Theuns DA, Jordaens LJ, Geleijnse ML.

J Am Soc Echocardiogr. 2009 Mar;22(3):232-9. doi: 10.1016/j.echo.2008.11.009. Epub 2008 Dec 19.

PMID:
19101112
15.

Ablation of idiopathic left ventricular tachycardia using remote magnetic navigation integrated with advanced mapping.

de Torres F, Szili-Torok T, Orellana FJ, Jordaens LJ.

Rev Esp Cardiol. 2008 Oct;61(10):1104-6. No abstract available.

16.

Morphology discrimination in implantable cardioverter-defibrillators: consistency of template match percentage during atrial tachyarrhythmias at different heart rates.

Theuns DA, Rivero-Ayerza M, Goedhart DM, Miltenburg M, Jordaens LJ.

Europace. 2008 Sep;10(9):1060-6. doi: 10.1093/europace/eun194. Epub 2008 Jul 28.

PMID:
18662939
17.

The ischemic etiology of heart failure in diabetics limits reverse left ventricular remodeling after cardiac resynchronization therapy.

Soliman OI, van Dalen BM, Theuns DA, ten Cate FJ, Nemes A, Jordaens LJ, Geleijnse ML.

J Diabetes Complications. 2009 Sep-Oct;23(5):365-70. doi: 10.1016/j.jdiacomp.2008.04.003. Epub 2008 Jun 24.

PMID:
18572420
18.

A fatal complication of ICD therapy due to lead failure.

Theuns DA, Szili-Torok T, Jordaens LJ.

J Cardiovasc Electrophysiol. 2008 Jul;19(7):E48. doi: 10.1111/j.1540-8167.2008.01215.x. Epub 2008 May 19. No abstract available.

PMID:
18554196
19.

Four-year follow-up of treatment with intramyocardial skeletal myoblasts injection in patients with ischaemic cardiomyopathy.

Veltman CE, Soliman OI, Geleijnse ML, Vletter WB, Smits PC, ten Cate FJ, Jordaens LJ, Balk AH, Serruys PW, Boersma E, van Domburg RT, van der Giessen WJ.

Eur Heart J. 2008 Jun;29(11):1386-96. doi: 10.1093/eurheartj/ehn171. Epub 2008 Apr 25.

PMID:
18441322
20.

Ablation of a focal left atrial tachycardia via a retrograde approach using remote magnetic navigation.

Thornton AS, Rivero-Ayerza M, Jordaens LJ.

Europace. 2008 Jun;10(6):687-9. doi: 10.1093/europace/eun080. Epub 2008 Apr 7. No abstract available.

PMID:
18397878
21.

Transcatheter ablation of arrhythmias associated with congenital heart disease.

Szili-Torok T, Kornyei L, Jordaens LJ.

J Interv Card Electrophysiol. 2008 Aug;22(2):161-6. doi: 10.1007/s10840-007-9198-6. Epub 2008 Mar 5. Review.

22.

Reverse of left ventricular volumetric and structural remodeling in heart failure patients treated with cardiac resynchronization therapy.

Soliman OI, Geleijnse ML, Theuns DA, Nemes A, Vletter WB, van Dalen BM, Motawea AK, Jordaens LJ, ten Cate FJ.

Am J Cardiol. 2008 Mar 1;101(5):651-7. doi: 10.1016/j.amjcard.2007.10.027. Epub 2008 Feb 21.

PMID:
18308015
23.

Predictors of cardiac events after cardiac resynchronization therapy with tissue Doppler-derived parameters.

Soliman OI, Theuns DA, Ten Cate FJ, Nemes A, Caliskan K, Balk AH, Vletter WB, Jordaens LJ, Geleijnse ML.

J Card Fail. 2007 Dec;13(10):805-11.

PMID:
18068612
24.

Symptoms versus objective rhythm monitoring in patients with paroxysmal atrial fibrillation undergoing pulmonary vein isolation.

Janse PA, van Belle YL, Theuns DA, Rivero-Ayerza M, Scholten MF, Jordaens LJ.

Eur J Cardiovasc Nurs. 2008 Jun;7(2):147-51. Epub 2007 Oct 17.

PMID:
17942370
25.

Tachyarrhythmias in Koch's triangle: to be burned out or to be cool?

Kimman GP, Szili-Torok T, Jordaens LJ.

Europace. 2007 Oct;9(10):906-8. Epub 2007 Aug 31. No abstract available.

PMID:
17766318
26.

Baseline predictors of cardiac events after cardiac resynchronization therapy in patients with heart failure secondary to ischemic or nonischemic etiology.

Soliman OI, Theuns DA, ten Cate FJ, Anwar AM, Nemes A, Vletter WB, Jordaens LJ, Geleijnse ML.

Am J Cardiol. 2007 Aug 1;100(3):464-9. Epub 2007 Jun 13.

PMID:
17659930
27.

A grateful heart.

Rivero-Ayerza M, Jessurun E, Theuns DA, Jordaens LJ.

Europace. 2007 Jul;9(7):533. Epub 2007 May 9. No abstract available.

PMID:
17491104
28.

Magnetic navigation in left-sided AV reentrant tachycardias: preliminary results of a retrograde approach.

Thornton AS, Rivero-Ayerza M, Knops P, Jordaens LJ.

J Cardiovasc Electrophysiol. 2007 May;18(5):467-72. Epub 2007 Mar 6.

PMID:
17343720
29.

Reversible left bundle branch block induced congestive heart failure. A case report.

van der Heijden R, Res JC, Jordaens LJ.

J Electrocardiol. 2007 Oct;40(4):348-51. Epub 2007 Jan 24.

PMID:
17254596
30.

Spectral pulsed-wave tissue Doppler imaging lateral-to-septal delay fails to predict clinical or echocardiographic outcome after cardiac resynchronization therapy.

Soliman OI, Theuns DA, Geleijnse ML, Anwar AM, Nemes A, Caliskan K, Vletter WB, Jordaens LJ, Cate FJ.

Europace. 2007 Feb;9(2):113-8. Epub 2007 Jan 11.

PMID:
17218390
31.

Left ventricular lead implantation assisted by magnetic navigation in a patient with a persistent left superior vena cava.

Rivero-Ayerza M, van Belle Y, Mekel J, Jordaens LJ.

Int J Cardiol. 2007 Mar 2;116(1):e15-7. Epub 2006 Nov 13.

PMID:
17098307
32.

Evaluation of morphology discrimination for ventricular tachycardia diagnosis in implantable cardioverter-defibrillators.

Theuns DA, Rivero-Ayerza M, Goedhart DM, van der Perk R, Jordaens LJ.

Heart Rhythm. 2006 Nov;3(11):1332-8. Epub 2006 Jul 8.

PMID:
17074640
33.

Magnetic assisted navigation in electrophysiology and cardiac resynchronisation: a review.

Thornton AS, Maximo Rivero-Ayerza M, Jordaens LJ.

Indian Pacing Electrophysiol J. 2006 Oct 1;6(4):202-13.

34.

Implantable defibrillator early after primary percutaneous intervention for ST-elevation myocardial infarction: rationale and design of the Defibrillator After Primary Angioplasty (DAPA) trial.

Ottervanger JP, Ramdat Misier AR, Zijlstra F, Schalij MJ, Wever E, Jordaens LJ, Henriques JP, de Boer MJ, Robbe HW, Wellens HJ; DAPA Investigators.

Am Heart J. 2006 Oct;152(4):636-40.

PMID:
16996827
35.

Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials.

Rivero-Ayerza M, Theuns DA, Garcia-Garcia HM, Boersma E, Simoons M, Jordaens LJ.

Eur Heart J. 2006 Nov;27(22):2682-8. Epub 2006 Sep 11. Review.

PMID:
16966347
36.

One-year follow-up in a prospective, randomized study comparing radiofrequency and cryoablation of arrhythmias in Koch's triangle: clinical symptoms and event recording.

Kimman GJ, Theuns DA, Janse PA, Rivero-Ayerza M, Scholten MF, Szili-Torok T, Jordaens LJ.

Europace. 2006 Aug;8(8):592-5. Epub 2006 Jun 27.

PMID:
16803840
37.

Use of advanced mapping and remote magnetic navigation to ablate left ventricular fascicular tachycardia.

Thornton AS, Res J, Mekel JM, Jordaens LJ.

Pacing Clin Electrophysiol. 2006 Jun;29(6):685-8.

PMID:
16784438
38.

Imaging of a coronary artery bypass graft during coronary sinus venography.

Thornton AS, Scholten MF, Jordaens LJ.

Cardiovasc J S Afr. 2006 Mar-Apr;17(2):73-4.

39.

Remote magnetic navigation for mapping and ablating right ventricular outflow tract tachycardia.

Thornton AS, Jordaens LJ.

Heart Rhythm. 2006 Jun;3(6):691-6. Epub 2006 Feb 28.

PMID:
16731472
40.

Targets and endpoints in ablation therapy for atrial fibrillation in the light of pathophysiological mechanisms.

Scholten MF, Thornton AS, Mekel JM, Jordaens LJ.

J Interv Card Electrophysiol. 2006 Jan;15(1):27-33. Review.

PMID:
16680547
41.

Magnetic navigation in AV nodal re-entrant tachycardia study: early results of ablation with one- and three-magnet catheters.

Thornton AS, Janse P, Theuns DA, Scholten MF, Jordaens LJ.

Europace. 2006 Apr;8(4):225-30. Epub 2006 Feb 21.

PMID:
16627445
42.

Left ventricular lead placement within a coronary sinus side branch using remote magnetic navigation of a guidewire: a feasibility study.

Rivero-Ayerza M, Thornton AS, Theuns DA, Scholten MF, Mekel JM, Res J, Jordaens LJ.

J Cardiovasc Electrophysiol. 2006 Feb;17(2):128-33.

PMID:
16533248
43.
44.

Intracardiac echocardiography during interventional procedures.

Vaina S, Ligthart J, Vijayakumar M, Ten Cate FJ, Witsenburg M, Jordaens LJ, Sianos G, Thornton AS, Scholten MF, de Jaegere P, Serruys PW.

EuroIntervention. 2006 Feb;1(4):454-64.

PMID:
19755221
45.

Ten year follow-up after radiofrequency catheter ablation for atrioventricular nodal reentrant tachycardia in the early days forever cured, or a source for new arrhythmias?

Kimman GP, Bogaard MD, van Hemel NM, van Dessel PF, Jessurun ER, Boersma LV, Wever EF, Theuns DA, Jordaens LJ.

Pacing Clin Electrophysiol. 2005 Dec;28(12):1302-9.

PMID:
16403162
46.

Pulmonary vein antrum isolation guided by phased-array intracardiac echocardiography: A third way to do PV ablation.

Scholten MF, Thornton AS, Mekel J, Rivero-Ayerza MJ, Marrouche NF, Jordaens LJ.

Neth Heart J. 2005 Dec;13(12):439-443.

47.

Defibrillation efficacy testing: long-term follow-up and mortality.

Theuns DA, Szili-Torok T, Jordaens LJ.

Europace. 2005 Nov;7(6):509-15. Epub 2005 Jul 18.

PMID:
16216750
48.

Outcome in patients with an ICD incorporating cardiac resynchronisation therapy: differences between primary and secondary prophylaxis.

Theuns DA, Thornton AS, Klootwijk AP, Scholten MF, Vantrimpont PJ, Balk AH, Jordaens LJ.

Eur J Heart Fail. 2005 Oct;7(6):1027-32. Epub 2005 Aug 16.

49.

Anticoagulation in atrial fibrillation and flutter.

Scholten MF, Thornton AS, Mekel JM, Koudstaal PJ, Jordaens LJ.

Europace. 2005 Sep;7(5):492-9. Review.

PMID:
16087116
50.

Atrial flutter: Watch and control?

Thornton AS, Jordaens LJ.

Europace. 2005 Sep;7(5):413-4. No abstract available.

PMID:
16087102

Supplemental Content

Loading ...
Support Center